Skip to main content

OPCAB Combined Regenerative Surgery

  • Chapter
Off-Pump Coronary Artery Bypass
  • 943 Accesses

Abstract

Patients with chorionic ischemic heart disease including irreversible myocardial damage cannot be completely restored by conventional coronary artery revascularization including coronary artery bypass grafting (CABG) or percutaneous coronary intervention (PCI).

Cell transplantation therapy for these patients has advantageous potential to improve left ventricle function with preventing ventricular remodeling and contractility of ventricle reduction. A number of animal studies have shown that intramyocardial cell transplantation in ischemic cardiomyopathy is associated with an improvement in ventricle function and consequently several clinical trials have evaluated clinical effectiveness of these therapies.

Various type of cell and methods have been used for intramyocardial cell transplantation; however, cell types with clinical utilization are bone marrow stem cell and skeletal myoblast.

Especially, intramyocardial bone marrow stem cell transplantation combined with CABG is a safe and available procedure with evidence of improving the left ventricle function in patients with chorionic ischemic heart disease. Furthermore, using off-pump CABG (OPCAB) technique may reduce intra- and postoperative complications in patients who have low cardiac function caused by prior myocardial infarction. Although the selection of patients is carefully treated, this combination therapy of cell transplantation and OPCAB can be advantageous option for ischemic heart disease.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 139.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Stamm C, Westphal B, Kleine HD, Petzsch M, Kittner C, Klinge H, Schümichen C, Nienaber CA, Freund M, Steinhoff G (2003) Autologous bone-marrow stem-cell transplantation for myocardial regeneration. Lancet 361(9351):45–46

    Article  PubMed  Google Scholar 

  2. Menasché P, Hagège AA, Scorsin M, Pouzet B, Desnos M, Duboc D, Schwartz K, Vilquin JT, Marolleau JP (2001) Myoblast transplantation for heart failure. Lancet 357(9252):279–280

    Article  PubMed  Google Scholar 

  3. Patel AN, Geffner L, Vina RF, Saslavsky J, Urschel HC Jr, Kormos R, Benetti F (2005) Surgical treatment for congestive heart failure with autologous adult stem cell transplantation: a prospective randomized study. J Thorac Cardiovasc Surg 130(6):1631–1638. Epub 2005 Oct 26

    Article  PubMed  Google Scholar 

  4. Hendrikx M, Hensen K, Clijsters C, Jongen H, Koninckx R, Bijnens E, Ingels M, Jacobs A, Geukens R, Dendale P, Vijgen J, Dilling D, Steels P, Mees U, Rummens JL (2006) Recovery of regional but not global contractile function by the direct intramyocardial autologousbone marrow transplantation: results from a randomized controlled clinical trial. Circulation 114(1 Suppl):I101–I107

    PubMed  Google Scholar 

  5. Stamm C, Kleine HD, Choi YH, Dunkelmann S, Lauffs JA, Lorenzen B, David A, Liebold A, Nienaber C, Zurakowski D, Freund M, Steinhoff G (2007) Intramyocardial delivery of CD133 + bone marrow cells and coronary artery bypass grafting for chronic ischemic heart disease: safety and efficacy studies. J Thorac Cardiovasc Surg 133(3):717–725. Epub 2007 Feb 1

    Article  PubMed  Google Scholar 

  6. Ang KL, Chin D, Leyva F, Foley P, Kubal C, Chalil S, Srinivasan L, Bernhardt L, Stevens S, Shenje LT, Galiñanes M (2008) Randomized, controlled trial of intramuscular or intracoronary injection of autologous bone marrow cells into scarred myocardium during CABG versus CABG alone. Nat Clin Pract Cardiovasc Med 5(10):663–670. doi:10.1038/ncpcardio1321. Epub 2008 Aug 19

    Article  PubMed  Google Scholar 

  7. Zhao Q, Sun Y, Xia L, Chen A, Wang Z (2008) Randomized study of mononuclear bone marrow cell transplantation in patients with coronary surgery. Ann Thorac Surg 86(6):1833–1840. doi:10.1016/j.athoracsur.2008.08.068

    Article  PubMed  Google Scholar 

  8. Hu S, Liu S, Zheng Z, Yuan X, Li L, Lu M, Shen R, Duan F, Zhang X, Li J, Liu X, Song Y, Wang W, Zhao S, He Z, Zhang H, Yang K, Feng W, Wang X (2011) Isolated coronary artery bypass graft combined with bone marrow mononuclear cells delivered through a graft vessel for patients with previous myocardial infarction and chronic heart failure: a single-center, randomized, double-blind, placebo-controlled clinical trial. J Am Coll Cardiol 57(24):2409–2415. doi:10.1016/j.jacc.2011.01.037

    Article  PubMed  Google Scholar 

  9. Yerebakan C, Kaminski A, Westphal B, Donndorf P, Glass A, Liebold A, Stamm C, Steinhoff G (2011) Impact of preoperative left ventricular function and time from infarction on the long-term benefits after intramyocardial CD133(+) bone marrow stem cell transplant. J Thorac Cardiovasc Surg 142(6):1530–1539.e3. doi: 10.1016/j.jtcvs.2011.05.002. Epub 2011 Jun 12

    Google Scholar 

  10. Strauer BE, Steinhoff G (2011) 10 years of intracoronary and intramyocardial bone marrow stem cell therapy of the heart: from the methodological origin to clinical practice. J Am Coll Cardiol 58(11):1095–1104. doi:10.1016/j.jacc.2011.06.016. Review

    Article  PubMed  Google Scholar 

  11. Dib N, Michler RE, Pagani FD, Wright S, Kereiakes DJ, Lengerich R, Binkley P, Buchele D, Anand I, Swingen C, Di Carli MF, Thomas JD, Jaber WA, Opie SR, Campbell A, McCarthy P, Yeager M, Dilsizian V, Griffith BP, Korn R, Kreuger SK, Ghazoul M, MacLellan WR, Fonarow G, Eisen HJ, Dinsmore J, Diethrich E (2005) Safety and feasibility of autologous myoblast transplantation in patients with ischemic cardiomyopathy: four-year follow-up. Circulation 112(12):1748–1755

    Article  PubMed  Google Scholar 

  12. Gavira JJ, Herreros J, Perez A, Garcia-Velloso MJ, Barba J, Martin-Herrero F, Cañizo C, Martin-Arnau A, Martí-Climent JM, Hernández M, López-Holgado N, González-Santos JM, Martín-Luengo C, Alegria E, Prósper F (2006) Autologous skeletal myoblast transplantation in patients with nonacute myocardial infarction: 1-year follow-up. J Thorac Cardiovasc Surg 131(4):799–804

    Article  PubMed  Google Scholar 

  13. Zhang D, Wang L, Zhang F, Li C, Zhu T, Cao K, Ma W, Yang Z (2013) Nine-year follow-up of local implantation of autologous skeletal myoblasts in a patient with coronary heart disease. Am J Case Rep 14:139–142. doi:10.12659/AJCR.883903. Print 2013

    Article  PubMed Central  PubMed  Google Scholar 

  14. Menasché P, Alfieri O, Janssens S, McKenna W, Reichenspurner H, Trinquart L, Vilquin JT, Marolleau JP, Seymour B, Larghero J, Lake S, Chatellier G, Solomon S, Desnos M, Hagège AA (2008) The Myoblast Autologous Grafting in Ischemic Cardiomyopathy (MAGIC) trial: first randomized placebo-controlled study of myoblast transplantation. Circulation 117(9):1189–1200. doi:10.1161/CIRCULATIONAHA.107.734103. Epub 2008 Feb 19

    Article  PubMed  Google Scholar 

  15. Nagamine H, Watanabe G, Shiobara S, Takemura H, Arai S, Tomita S (2004) Intramyocardial CD34 + cell transplantation combined with off-pump coronary artery bypass grafting. Heart Surg Forum 7(4):E285–E287

    Article  PubMed  Google Scholar 

  16. Donndorf P, Kundt G, Kaminski A, Yerebakan C, Liebold A, Steinhoff G, Glass A (2011) Intramyocardial bone marrow stem cell transplantation during coronary artery bypass surgery: ameta-analysis. J Thorac Cardiovasc Surg 142(4):911–920. doi:10.1016/j.jtcvs.2010.12.013. Epub 2011 Mar 3. Review

    Article  PubMed  Google Scholar 

  17. Shudo Y, Miyagawa S, Fukushima S, Saito A, Shimizu T, Okano T, Sawa Y (2011) Novel regenerative therapy using cell-sheet covered with omentum flap delivers a huge number of cells in a porcine myocardial infarction model. J Thorac Cardiovasc Surg 142(5):1188–1196. doi:10.1016/j.jtcvs.2011.07.002. Epub 2011 Sep 14

    Article  PubMed  Google Scholar 

  18. Kanamori T, Watanabe G, Yasuda T, Nagamine H, Kamiya H, Koshida Y (2006) Hybrid surgical angiogenesis: omentopexy can enhance myocardial angiogenesis induced by cell therapy. Ann Thorac Surg 81(1):160–167

    Article  PubMed  Google Scholar 

  19. Kawamura M, Miyagawa S, Fukushima S, Saito A, Miki K, Ito E, Sougawa N, Kawamura T, Daimon T, Shimizu T, Okano T, Toda K, Sawa Y (2013) Enhanced survival of transplanted human induced pluripotent stem cell-derived cardiomyocytes by the combination of cell sheets with the pedicled omental flap technique in a porcine heart. Circulation 128(11 Suppl 1):S87–S94. doi: 10.1161/CIRCULATIONAHA.112.000366

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Shigeyuki Tomita .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer Japan

About this chapter

Cite this chapter

Tomita, S., Watanabe, G. (2016). OPCAB Combined Regenerative Surgery. In: Asai, T., Ochi, M., Yokoyama, H. (eds) Off-Pump Coronary Artery Bypass. Springer, Tokyo. https://doi.org/10.1007/978-4-431-54986-4_29

Download citation

  • DOI: https://doi.org/10.1007/978-4-431-54986-4_29

  • Publisher Name: Springer, Tokyo

  • Print ISBN: 978-4-431-54985-7

  • Online ISBN: 978-4-431-54986-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics